Robert Langer, 10% Owner at INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV), sold 7,500 shares at $2.85 ($21K) on 2013-05-15, disclosed to the SEC on 2013-05-17.
Scheduled sale ($21k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 2,500 | $7K | 33.3% |
| 2 | $2.84 | 2,500 | $7K | 33.2% |
| 3 | $2.86 | 2,500 | $7K | 33.5% |
| Total | $2.85 avg | 7,500 | $21K | 100% |
| Filing → |
| RUBY | SELL | 2019-04-17 | $132K | — | Filing → |
| RUBY | SELL | 2019-01-18 | $109K | — | Filing → |
| NVIV | SELL | 2013-06-05 | $28K | — | Filing → |